ResApp Health engages UK-based consultant

Company News

by Rachael Jones

Digital health company ResApp Health (ASX:RAP) has engaged a UK-based medical device consultant to develop customised hardware and wearable devices capable of running their algorithms.

They are focused on delivering mobile software apps in multiple clinical settings including telehealth, emergency, urgent care and primary care.

The design consultancy will work with leading UK-based medical device manufacturers, OSI Electronics, to design, test and finalise two CE-marked devices.

They include a lowcosthandheld device and a small, wearable breathing monitor.

The wearable monitor will provide ResApp with an easily worn, unobtrusive platform for monitoring patients with chronic disease 24/7 over extended periods.

Shares in ResApp Health 16.67 per cent higher at $0.175 yesterday. 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.